Attenuating the Epidermal Growth Factor Receptor–Extracellular Signal‐Regulated Kinase–Sex‐Determining Region Y‐Box 9 Axis Promotes Liver Progenitor Cell‐Mediated Liver Regeneration in Zebrafish

Juhoon So, Minwook Kim, Seung‐Hoon Lee, Sungjin Ko, Daniel A. Lee, Hyewon Park, Mizuki Azuma, Michael J. Parsons, David Prober, Donghun Shin – 29 June 2020

Retracted: M2 Macrophage–Derived Exosomes Facilitate HCC Metastasis by Transferring αMβ2 Integrin to Tumor Cells

Jindao Wu, Wen Gao, Qiyun Tang, Yue Yu, Wei You, Zhengshan Wu, Ye Fan, Long Zhang, Chen Wu, Guoyong Han, Xueliang Zuo, Yao Zhang, Zhiqiang Chen, Wenzhou Ding, Xiangcheng Li, Fengming Lin, Hongbing Shen, Jinhai Tang, Yaqin Zhang, Xuehao Wang – 28 June 2020

Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System

Fuzhen Wang, Xiaojin Sun, Feng Wang, Hui Zheng, Zhiyuan Jia, Guomin Zhang, Shengli Bi, Ning Miao, Shuang Zhang, Fuqiang Cui, Li Li, Huaqing Wang, Xiaofeng Liang, Lance E. Rodewald, Zijian Feng, Zundong Yin, Liping Shen – 26 June 2020

Genome‐Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study

S. Lani Park, Yuqing Li, Xin Sheng, Victor Hom, Lucy Xia, Kechen Zhao, Loreall Pooler, V. Wendy Setiawan, Unhee Lim, Kristine R. Monroe, Lynne R. Wilkens, Bruce S. Kristal, Johanna W. Lampe, Meredith Hullar, John Shepherd, Lenora L. M. Loo, Thomas Ernst, Adrian A. Franke, Maarit Tiirikainen, Christopher A. Haiman, Daniel O. Stram, Loïc Le Marchand, Iona Cheng – 25 June 2020 – The global rise in fatty liver is a major public health problem. Thus, it is critical to identify both global and population‐specific genetic variants associated with liver fat.

Immunosuppression in Donation After Circulatory Death Liver Transplantation: Can Induction Modify Graft Survival?

Kevin Ig‐Izevbekhai, David S. Goldberg, Seth J. Karp, David P. Foley, Peter L. Abt – 24 June 2020 – Recipients of donation after circulatory death (DCD) LTs historically have an increased risk of graft failure. Antibody induction (AI) with antithymocyte globulin (ATG) or anti‐interleukin 2 receptor (anti‐IL2R) immunotherapy may decrease the incidence of graft failure by mitigating ischemia/reperfusion injury.

Subscribe to